BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26424021)

  • 1. Biological Responsiveness and Metabolic Performance of Liposome-Encapsulated Hemoglobin (Hemoglobin-Vesicles) in Apolipoprotein E-Deficient Mice after Massive Intravenous Injection.
    Taguchi K; Nagao S; Yamasaki K; Sakai H; Seo H; Maruyama T; Otagiri M
    Biol Pharm Bull; 2015; 38(10):1606-16. PubMed ID: 26424021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatically-metabolized and -excreted artificial oxygen carrier, hemoglobin vesicles, can be safely used under conditions of hepatic impairment.
    Taguchi K; Miyasato M; Ujihira H; Watanabe H; Kadowaki D; Sakai H; Tsuchida E; Horinouchi H; Kobayashi K; Maruyama T; Otagiri M
    Toxicol Appl Pharmacol; 2010 Nov; 248(3):234-41. PubMed ID: 20709091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier.
    Taguchi K; Urata Y; Anraku M; Maruyama T; Watanabe H; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Kai T; Otagiri M
    Drug Metab Dispos; 2009 Jul; 37(7):1456-63. PubMed ID: 19364827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated injection of high doses of hemoglobin-encapsulated liposomes (hemoglobin vesicles) induces accelerated blood clearance in a hemorrhagic shock rat model.
    Taguchi K; Iwao Y; Watanabe H; Kadowaki D; Sakai H; Kobayashi K; Horinouchi H; Maruyama T; Otagiri M
    Drug Metab Dispos; 2011 Mar; 39(3):484-9. PubMed ID: 21123166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days.
    Sakai H; Masada Y; Horinouchi H; Ikeda E; Sou K; Takeoka S; Suematsu M; Takaori M; Kobayashi K; Tsuchida E
    J Pharmacol Exp Ther; 2004 Dec; 311(3):874-84. PubMed ID: 15297471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice.
    Taguchi K; Urata Y; Anraku M; Watanabe H; Kadowaki D; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Maruyama T; Otagiri M
    Drug Metab Dispos; 2009 Nov; 37(11):2197-203. PubMed ID: 19679674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome-encapsulated hemoglobin (hemoglobin-vesicle) is not transferred from mother to fetus at the late stage of pregnancy in the rat model.
    Kaga M; Li H; Ohta H; Taguchi K; Ogaki S; Izumi H; Inagaki M; Tsuchiya S; Okamura K; Otagiri M; Sakai H; Yaegashi N
    Life Sci; 2012 Oct; 91(11-12):420-428. PubMed ID: 22935405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary and secondary immune responses to keyhole limpet hemocyanin in rats after infusion of hemoglobin vesicle, an artificial oxygen carrier.
    Fujihara M; Takahashi D; Abe H; Sakai H; Horinouchi H; Kobayashi K; Ikeda H; Azuma H
    Artif Organs; 2014 Mar; 38(3):234-8. PubMed ID: 24033558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic administration of hemoglobin vesicle elevates tumor tissue oxygen tension and modifies tumor response to irradiation.
    Yamamoto M; Izumi Y; Horinouchi H; Teramura Y; Sakai H; Kohno M; Watanabe M; Kawamura M; Adachi T; Ikeda E; Takeoka S; Tsuchida E; Kobayashi K
    J Surg Res; 2009 Jan; 151(1):48-54. PubMed ID: 18262559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiopulmonary hemodynamic responses to the small injection of hemoglobin vesicles (artificial oxygen carriers) in miniature pigs.
    Sakai H; Suzuki Y; Sou K; Kano M
    J Biomed Mater Res A; 2012 Oct; 100(10):2668-77. PubMed ID: 22615268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model.
    Sakai H; Horinouchi H; Masada Y; Takeoka S; Ikeda E; Takaori M; Kobayashi K; Tsuchida E
    Biomaterials; 2004 Aug; 25(18):4317-25. PubMed ID: 15046922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic study following administration of liposome-encapsulated hemoglobin in the normovolemic rat.
    Rudolph AS; Spielberg H; Spargo BJ; Kossovsky N
    J Biomed Mater Res; 1995 Feb; 29(2):189-96. PubMed ID: 7738065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year observation of Wistar rats after intravenous infusion of hemoglobin-vesicles (artificial oxygen carriers).
    Sakai H; Tsuchida E; Horinouchi H; Kobayashi K
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):81-91. PubMed ID: 17364473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 days.
    Sakai H; Seishi Y; Obata Y; Takeoka S; Horinouichi H; Tsuchida E; Kobayashi K
    Shock; 2009 Feb; 31(2):192-200. PubMed ID: 18520699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin-vesicles as an artificial oxygen carrier.
    Sakai H; Sou K; Tsuchida E
    Methods Enzymol; 2009; 465():363-84. PubMed ID: 19913177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple responses to administration of liposome-encapsulated hemoglobin (LEH): Effects on hematopoiesis and serum IL-6 levels.
    Rollwagen FM; Gafney WC; Pacheco ND; Davis TA; Hickey TM; Nielsen TB; Rudolph AS
    Exp Hematol; 1996 Feb; 24(3):429-36. PubMed ID: 8599972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system.
    Sakai H; Horinouchi H; Tomiyama K; Ikeda E; Takeoka S; Kobayashi K; Tsuchida E
    Am J Pathol; 2001 Sep; 159(3):1079-88. PubMed ID: 11549600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute.
    Sou K; Klipper R; Goins B; Tsuchida E; Phillips WT
    J Pharmacol Exp Ther; 2005 Feb; 312(2):702-9. PubMed ID: 15459236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulated hemoglobin: current issues and future goals.
    Rudolph AS
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(2):347-60. PubMed ID: 8087251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentially increased IL-6 mRNA expression in liver and spleen following injection of liposome-encapsulated haemoglobin.
    Zhu XL; Pacheco ND; Dick EJ; Rollwagen FM
    Cytokine; 1999 Sep; 11(9):696-703. PubMed ID: 10479406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.